Andrew D. Ashe - 25 Aug 2022 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
President, Chief Operating Officer and General Counsel
Signature
/s/ Andrew Ashe
Issuer symbol
VERV
Transactions as of
25 Aug 2022
Net transactions value
+$152,217
Form type
4
Filing time
29 Aug 2022, 17:00:23 UTC
Previous filing
15 Feb 2022
Next filing
16 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERV Common Stock Options Exercise $71,172 +51,203 +30% $1.39* 221,925 25 Aug 2022 Direct
transaction VERV Common Stock Options Exercise $49,949 +33,749 +15% $1.48* 255,674 25 Aug 2022 Direct
transaction VERV Common Stock Options Exercise $31,096 +10,835 +4.2% $2.87* 266,509 25 Aug 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERV Stock Option (right to buy) Options Exercise $0 -51,203 -100% $0.000000* 0 25 Aug 2022 Common Stock 51,203 $1.39 Direct F1
transaction VERV Stock Option (right to buy) Options Exercise $0 -33,749 -56% $0.000000 26,999 25 Aug 2022 Common Stock 33,749 $1.48 Direct F2
transaction VERV Stock Option (right to buy) Options Exercise $0 -10,835 -6.6% $0.000000 153,278 25 Aug 2022 Common Stock 10,835 $2.87 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The remaining shares underlying this option, which was granted on November 8, 2018, were fully vested as of August 20, 2022.
F2 The remaining shares underlying this option, which was granted on September 17, 2019, vest in equal monthly installments until July 26, 2023.
F3 The remaining shares underlying this option, which was granted on September 16, 2020, vest in equal monthly installments until September 16, 2024.

Remarks:

President, Chief Operating Officer and General Counsel